# Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)

> **NCT04866082** · — · COMPLETED · sponsor: **Brno University Hospital** · enrollment: 466 (actual)

## Conditions studied

- Severe COVID-19

## Interventions

- **OTHER:** questionnaire

## Key facts

- **NCT ID:** NCT04866082
- **Lead sponsor:** Brno University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-30
- **Primary completion:** 2022-06-14
- **Final completion:** 2022-06-30
- **Target enrollment:** 466 (ACTUAL)
- **Last updated:** 2023-02-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866082, "Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04866082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*